Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

How intrinsic sympathomimetic activity modulates the haemodynamic responses to beta‐adrenoceptor antagonists. A clue to the nature of their antihypertensive mechanism.

1982; Wiley; Volume: 13; Issue: S2 Linguagem: Inglês

10.1111/j.1365-2125.1982.tb01922.x

ISSN

1365-2125

Autores

Man in't AJ Veld, MA Schalekamp,

Tópico(s)

Heart Rate Variability and Autonomic Control

Resumo

British Journal of Clinical PharmacologyVolume 13, Issue S2 p. 245S-257S Free Access How intrinsic sympathomimetic activity modulates the haemodynamic responses to beta-adrenoceptor antagonists. A clue to the nature of their antihypertensive mechanism. Man in't AJ Veld, Man in't AJ VeldSearch for more papers by this authorMA Schalekamp, MA SchalekampSearch for more papers by this author Man in't AJ Veld, Man in't AJ VeldSearch for more papers by this authorMA Schalekamp, MA SchalekampSearch for more papers by this author First published: April 1982 https://doi.org/10.1111/j.1365-2125.1982.tb01922.xCitations: 73AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat References ADOLFSSON, L. & SONNHAG, C. (1976). Hemodynamic effects of two cardioselective β-adrenoceptive antagonists, metoprolol and H 87/07, in coronary insufficiency. Scand. J. clin. lab. Invest., 36, 755– 761. AMERY, A., BILLIET, L., BOEL, A., FAGARD, R., REYBROEK, T. & WILLEMS, J. (1976). Mechanism of hypotensive effect during β-adrenergic blockade in hypertensive patients. Am. Heart J., 91, 634– 642. ANAVEKAR, S.N., LOUIS, W.J., MORGAN, T.O., DOYLE, A.E. & JOHNSTON, C.I. (1975). The relationship of plasma levels of pindolol in hypertensive patients to effects on blood pressure, plasma renin and plasma noradrenaline levels. Clin. exp. Pharmac. Phys., 2, 203– 212. ANDERSON, O. & BERGLUND, G. (1975). Antihypertensive effect of β1-receptor blockade and β2-receptor stimulation in essential hypertension. Acta med. Scand. 197, 495– 496. ARONOW, W.S., FERLINZ, J., DEL VICARIO, M., MOORTHY, K., KING, J. & CASSIDY, J. (1976). Effects of timolol versus propranolol on hypertension and hemodynamics. Circulation, 54, 47– 51. ÄSTRÖM, H. & JONSSON, B. (1977). Haemodynamic effects of different β-blockers in angina pectoris. Scot. med. J., 22, 64– 68. ATTERHÖG, J.H., DUNÉR, H. & PERNOW, B. (1976). Experience with pindolol, a β-receptor blocker, in the treatment of hypertension. Am. J. Med., 60, 872– 876. ATTERHÖG, J.H., DUNÉR, H. & PERNOW, B. (1977a). Hemodynamic effect of long-term treatment with pindolol in essential hypertension with special reference to the resistance and capacitance vessels of the forearm. Acta med. Scand., 202, 517– 521. ATTERHÖG, J.H., DUNÉR, H. & PERNOW, B. (1977b). Haemodynamic studies with pindolol in hypertension. Curr. med. Res. Opin., 4, Suppl. 5, 39– 44. BANNAN, L.T. & BEEVERS, D.G. (1981). Emergency treatment of high blood pressure with oral atenolol. Br. med. J., 282, 1757– 1758. BERTHELSEN, S. & PETTINGER, W.A. (1977). A functional basis for classification of α-adrenergic receptors. Life Sci., 21, 595– 606. BIAMINO, G. (1980). Kardiovaskuläre Effekte von Penbutolol in Ruhe und unter Belastungsbedingungen. Herz Kreisl, 12, 527– 537. BIRKENHÄGER, W.H., KRAUSS, X.H., SCHALEKAMP, M.A.D.H., KOLSTERS, G. & KROON, B.J.M. (1971). Antihypertensive effects of propranolol. Folia med. Neerl, 14, 67– 71. BLACK, J.W. & STEPHENSON, J.S. (1962). Pharmacology of a new adrenergic β-receptor blocking compound (nethalidine). Lancet, ii, 311– 314. BODEM, G., BRAMMELL, H.L., WEIL, J.H. & CHIDSEY, C.A. (1973). Pharmacodynamic studies of β-adrenergic antagonism induced in man by propranolol and practolol. J. clin. Invest., 82, 747– 754. BRECHT, H.M., BANTHIEN, F. & SCHOEPPE, W. (1976a). Decrease in plasma noradrenaline levels following long-term treatment with pindolol in patients with essential hypertension. Klin. Wschr., 94, 1095– 1105. BRECHT, H.M., BANTHIEN, F., ERNST, W. & SCHOEPPE, W. (1976b). Increased plasma adrenaline concentrations in essential hypertension and their decrease after long-term treatment with a β-receptor blocking agent (pindolol). Clin. Sci. mol. Med., 51, Suppl. 3, 485s– 488s. BÜHLER, F.R., LARAGH, J.H., BAER, L., VAUGHAN, E.P. & BRUNNER, H.J. (1972). Propranolol inhibition of renin secretion. New Engl. J. med., 287, 1209– 1214. BÜHLER, F.R., LARAGH, J.H., DARACOTT-VAUGHAN, E., BRUNNER, H.R., GAVRAS, H. & BAER, L. (1973). Antihypertensive action of propranolol. Specific anti-renin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertension. Am. J. Cardiol., 32, 511– 522. CASTENFORS, J., JOHNSSON, H. & ORO, L. (1973). Effect of alprenolol on blood pressure and plasma renin activity in hypertensive patients. Acta med. Scand., 193, 189– 193. CHEW, C.Y., COLLETT, J., SHAH, P.K. & SINGH, B.N. (1979). Hemodynamic effects of intravenous timolol in coronary artery disease. Clin. Pharmac. Ther., 26, 330– 338. CLARK, B.J., MENNINGER, K. & BERTHOLET, A. (1982). Pindolol, the pharmacology of partial agonists. Br. J. clin. Pharmac., 13, 149– 158. CONWAY, J. (1980). The antihypertensive action of β-adrenoceptor blocking agents. In: Clinical Pharmacology of Antihypertensive Agents, ed K.H. Rahn & H.R.J Struyker-Boudier. CRYER, P.E., RIZZA, R.A., HAMMOND, M.W. & GERICH, J.E. (1980). Epinephrine and norepinephrine are cleared through β-adrenergic, but not α-adrenergic mechanisms in man. Metabolism, 29, Suppl. 1, 1114– 1118. DE LEEUW, P.W., FALKE, H.E., KHO, T.L., VANDONGEN, R., WESTER, A. & BIRKENHÄGER, W.H. (1977). Effects of β-adrenergic blockade on diurnal variability of blood pressure and plasma noradrenaline levels. Acta med. Scand., 202, 389– 392. DISTLER, A., KEIM, H.J., CORDES, U., PHILIPP, T. & WOLFF, H.P. (1978). Sympathetic responsiveness and antihypertensive effect of β-receptor blockade in essential hypertension. Am. J. Med., 64, 446– 451. DOYLE, A.E. (1974). Use of β-adrenoceptor blocking drugs in hypertension. Drugs, 8, 422– 431. DRESLINSKI, G.R., ARISTIMUNO, G.G., MESSERLI, F.H., SUAREZ, D.H. & FROHLICH, E.D. (1979). Effects of beta blockade on hypertension, haemodynamics and fluid volume. Clin. Pharmac. Ther., 26, 562– 565. DUNN, F.G., CARVALHO, J.G.R. & FROHLICH, E.D. (1979). Hemodynamic effects of intravenous and prolonged oral timolol therapy in essential hypertension. In: Proceedings of the timolol international symposium, Stockholm-Sweden, October 27th-28th, 1979, eds B.G. Hansson, S. Julius & P. Richardson pp. 159– 173. New York: BMI. ELIASSON, K., LINS, L.E. & SUNDQVIST, K. (1979). Long-term hemodynamic effects of timolol in essential hypertension. In: Proceedings of the timolol international symposium, Stockholm-Sweden, October 27th-28th, 1979, eds B.G. Hansson, S. Julius & P. Richardson pp. 145– 157. New York. BMI. ESLER, M.D. & NESTEL, P.J. (1973). Evaluation of practolol in hypertension. Br. Heart J., 35, 469– 474. ESLER, M.D., JACKMAN, G., LEONARD, P., SKEWS, H., BOBIK, A., JENNINGS, G. (1981). Effect of propranolol on noradrenaline kinetics in patients with essential hypertension. Br. J. clin. Pharmac., 12, 375– 380. FAGARD, F., AMERY, A., DE PLAEN, J.F., LIJNEN, P. & MISSOTTEN, A. (1976). Plasma renin concentration and the hypotensive effect of bendrofluazide and of atenolol. Clin. Sci. mol. Med., 51, 215s– 217s. FITZGERALD, J.D., RUFFIN, R., SMEDSTAD, K.G., ROBERTS, R. & McAINSH, J. (1978). Studies on the pharmacokinetics and pharmacodynamics of atenolol in man. Eur. J. clin. Pharmac., 13, 81– 89. FORSBERG, S.A. & JOHNSSON, G. (1967). Hemodynamic effects of propranolol and H 56/28 in man, a comparative study of two β-adrenergic receptor antagonists. Acta Pharmac. Tox., 25, Suppl. 2, 75– 83. FRANZ, I.W., LOHMANN, F.W. & KOCH, G. (1980). Differential effects of long-term cardioselective and nonselective β-receptor blockade on plasma catecholamines during and after physical exercise in hypertensive patients. J. cardiovasc. Pharmac., 2, 35– 44. FRISK-HOLMBERG, M., JORFELDT, L. & JUHLIN-DANNFELDT, A. (1977). Influence of alprenolol on hemodynamic and metabolic responses to prolonged exercise in subjects with hypertension. Clin. Pharmac. Ther., 21, 675– 684. GAVRAS, I., GAVRAS, H., TIFFT, C.P., KERSHAW, G.R. & BRESHNAHAN, M. (1981). Effect of pindolol on blood pressure, plasma renin activity, and catecholamines in hypertensive patients. J. clin. Pharmac., 21, 79– 83. GEBHART, W. (1968). Wirkungsunterschiede einiger β-Rezeptorenblocker auf Herz- und Kreislaufdynamik in Ruhe und bei Ergometerbelastung. In: Aktuelle Probleme der β-Rezeptorenblockade, Intern. Symp. Kronberg/Taunus, 19th-20th October, 1968. pp. 47– 62, 1970. Stuttgart/New York: F.G. Schattauer Verlag. GORDON, R.D. (1976). Effects of β-adrenoceptor blocking drugs on plasma volume, renin and aldosterone as compounds of their antihypertensive action. Drugs, 11, Suppl. 1, 156– 163. GRANDJEAN, T. & RIVIER, J.L. (1968). Cardiocirculatory effects of β-adrenergic blockade in organic heart disease. Heart J., 30, 50– 59. GUYTON, A.C., GRANGER, H.J. & COLEMAN, T.G. (1971). Autoregulation of the total systemic circulation and its relation to control of cardiac output and arterial pressure. Circulation Res., 28, Suppl. 1, 93– 99. HANSSON, L. (1973). Beta-adrenergic blockade in essential hypertension. Effects of propranolol in haemodynamic parameters and plasma renin activity. Acta med. Scand., 55, Suppl., 1– 40. HANSSON, B.G., DYMLING, I.F., HEDELAND, H. & HULTHEN, U.L. (1977). Long-term treatment of moderate hypertension with the β1-receptor blocking agent metoprolol. Eur. J. clin. Pharmac. 11, 239– 245. HANSSON, B.G. & HÖKFELT, B. (1975). Long-term treatment of moderate hypertension with penbutolol (Hoe 893 d). Eur. J. clin. Pharmac., 9, 9– 19. HANSSON, L., MALMcRONA, R., OLANDER, R., ROSENHALL, B., WESTERLUND, A., ABERG, H. & HOOD, B. (1972). Propranolol in hypertension. Klin. Wschr., 50, 364– 369. HANSSON, L., ZWEIFFLER, A.J., JULIUS, S. & ELLIS, C.N. (1974a). Propranolol therapy in essential hypertension. Observations on predictability of therapeutic responses. Int. J. clin. Pharmac., 10, 79– 89. HANSSON, L., ZWEIFFLER, A.J., JULIUS, S. & HUNYOR, S.N. (1974b). Hemodynamic effects of acute and prolonged β-adrenergic blockade in essential hypertension. Acta med. Scand., 196, 27– 34. HARTLING, O.J., NOER, I., SVENDSEN, T.J., CLAUSEN, J.P. & TRAP-JENSEN (1980). Selective and nonselective β-adrenoceptor blockade in the human forearm. Clin. Sci., 58, 279– 286. HJEMDAHL, P., POLLARE, T., GILLBERG, M. & AKERSTEDT (1980). Concentration-effect relationships for infused catecholamines in man: influence of propranolol and metoprolol. Naunyn-Schmiedeberg's Arch. Pharmac., 313, R60. IRELAND, M.A. & LITTLER, W.A. (1981). The effects of oral acebutolol and propranolol on forearm blood flow in hypertensive patients. Br. J. clin. Pharmac., 12, 363– 368. ISBARY, J., GREDING, H., NECHWATAL, W. & KÖNIG, E. (1978). Hämodynamische Veränderungen bei Hypertoniker nach β-Sympathikolyse mit Propranolol und Metoprolol. Z. Kardiol, 67, 857– 862. JENSEN, H.A.E., RASMUSSEN, K. & MOSBAEK, N. (1976). Clinical and haemodynamic study of atenolol (Tenormin) in essential hypertension. Clin. Sci. mol. Med., 51, 525s– 526s. JOHNSSON, G., GUZMAN, M., BERGMAN, H. & SANNERSTEDT (1969). The haemodynamic effects of alprenolol and propranolol at rest and during exercise in hypertensive patients. Pharmacol Clin., 2, 34– 39. KIRSTEN, K., HEINTZ, B., NELSON, K. & ROTH, S. (1982). Plasma catacholamines in essential hypertension - Influence of pindolol and propranolol. Br. J. clin. Pharmac., 13, 397s– 406s. KLEIN, W.W., BRANDT, D., FLUCH, N., GOEBEL, R., HOLZER, H. & PÖCH, G. (1976). Hamodynamische Langzeiteffekte eines β-Rezeptorenblockers (Pindolol) bei primarer arterieller Hypertonic In β-Blocker in der Hypertonia-Behandlung. eds G. Hitzenberger, Urban & Schwarzenberg, pp. 79– 85. Miinchen, Wien, Baltimore. KREDIET, R.T. & DUNNING, A.J. (1979). Baroreflex sensitivity in hypertension during beta-adrenergic blockade. Br. Heart J., 41, 106– 110. KURAMOTO, K., MATSUSHITA, T., MIFUNE, J., SAKAI, M., KURIHARA, H. & MURAKAMI, T. (1974). Actions of pindolol on blood pressure, hemodynamics, renin-activity in senile hypertensive patients. Rinsko-to-Kenkyu, 51, 2958– 2962. LANG, E. & HOLTMANN, W. (1974). Veränderungen der Hämodynamik unter dem Einflusz der β-Sympathikolyse bei zwei verschiedenen Substanzen unterschiedlichen pharmakodynamischen Prinzips. Arzneimittel-Forsch, 24, 1330– 1335. LANG, R., MAXRATH, A., LAASER, U., MEURER, K.A. & KAUFMANN, W. (1978). Zur Bedeutung einer Änderung der Gesamt-Bilanz von Natrium und Noradrenalin bei essentieller Hypertonic Klin. Wschr., 56, 1097– 1108. LANGER, S.Z. (1977). Presynaptic receptors and their role in the regulation of transmitter release. Br. J. Pharmac., 60, 481– 497. LEONETTI, G., TERZOLI, L., BIANCHINI, C., SALA, C. & ZANCHETTI, A. (1980). Time-course of the antihypertensive action of atenolol; comparison of response to first dose and to maintained oral administration. Eur. J. clin. Pharmac., 18, 365– 374. LEWIS, B.S., BAKST, A., MITHA, A.S., PURDON, K. & GOTSMAN (1973). Haemodynamic effects of a new β-blocking agent "Sectral" (M&B 17803 A). Br. Heart J., 85, 743– 751. LEWIS, B.S., MITHA, A.S., BAKST, A., PURDON, K. & GOTSMAN, M.S. (1974). Haemodynamic effects of β-blockade in hypertrophic cardiomyopathy using Sectral (acebutolol; M&B 17803 A). Cardiov. Res., 8, 249– 262. LEWIS, M.J. (1974). Effect of acute and chronic treatment with practolol on cardiovascular responses in the pithed rat. J. Pharm. Pharmac., 26, 783– 788. LIJNEN, P.J., AMERY, A.M., FAGARD, R.H. & REY-BROUCK, T.M. (1979). The effects of β-adrenoceptor blockade on renin, angiotensin, aldosterone and catecholamines at rest and during exercise. Br. J. clin. Pharmac., 7, 175– 181. UUNG, B., ABLAD, B., DAHLOF, C., HENNING, M. & HULTBERG, E. (1975). Impaired vasoconstrictor nerve function in spontaneously hypertensive rats after long-term treatment with propranolol and metoprolol. Blood Vessels, 12, 311– 315. LUND-JOHANSEN, P. (1976a). Haemodynamic long-term effects of a new β-adrenergic blocking drug, atenolol (ICI 66082), in essential hypertension. Br. J. clin. Pharmac, 3, 445– 451. LUND-JOHANSEN, P. (1976c). Hemodynamic long-term effects of timolol at rest and during exercise in essential hypertension. Acta. med. Scand., 199, 263– 267. LUND-JOHANSEN, P. (1979a). Hemodynamic consequences of long-term beta-blocker therapy: A 5-year follow-up study of atenolol. J. cardiov. Pharmac., 1, 487– 495. LUND-JOHANSEN, P. (1979b). Comparative haemodynamic effects of labetolol, timolol, prazosin and the combination of tolamolol and prazosin. Br. J. clin. Pharmac., Suppl. 2, 8, 107s– 111s. LUND-JOHANSEN, P. (1979c). Long-term hemodynamic effects of penbutolol at rest and during exercise in essential hypertension. Eur. J. clin. Pharmac., 16, 149– 153. LUND-JOHANSEN, P. & OHM, O.J. (1976). Haemodynamic long-term effects of β-receptor blocking agents in hypertension: a comparison between alprenolol, atenolol, metoprolol and timolol. Clin. Sci. mol. Med., 51, 481s– 483s. LUND-JOHANSEN, P. & OHM, O.J. (1977). Haemodynamic long-term effects of metoprolol at rest and during exercise in essential hypertension. Br. J. clin. Pharmac., 4, 147– 151. LUND-LARSEN, G. & SIVERTSSEN, E. (1969). Hemodynamic effects of propranolol (Inderal) and H 56/28 (Aptin) in patients with acute myocardial infarction. Acta med. Scand., 186, 187– 191. SVENDSEN, LYSBO T., HARTLING, O. & TRAP-JENSEN, J. (1979a). Immediate haemodynamic effects of propranolol, practolol, pindolol, atenolol and ICI 89, 406 in healthy volunteers. Eur. J. clin. Pharmac., 15, 223– 228. SVENDSEN, LYSBO T., TRAP-JENSEN, J., BLIDDAL, J., HARTLING, O. & McNAIR, A. (1979b). Acute hemodynamic effects of five β-adrenoceptor blocking agents in man: the significance of selectivity and intrinsic sympathomimetic activity. Acta med. Scand., 625, 26– 30. SVENDSEN, LYSBO T., TANGØ, M., WALDORFF, S., STEINESS, E. & TRAP-JENSEN, J. (1982). Effects of propranolol and pindolol on the plasma lignocaine clearance in man. Br. J. clin. Pharmac., 13, 223s– 224s. MAJEWSKI, H., McCULLOCH, M.W., RAND, M.J. & STORY, D.F. (1980). Adrenaline activation of prejunctional β-adrenoceptors in guinea pig atria. Br. J. Pharmac., 71, 435– 444. MAJEWSKI, H., TUNG, L.H. & RAND, M.J. (1981). Adrenaline-induced hypertension in rats. J. cardiov. Pharmac., 3, 179– 185. MAJID, P.A., SHARMA, B., SAXTON, C., STOKER, J.B. & TAYLOR, S.H. (1970). Haemodynamic effects of oxprenolol in hypertensive patients. Postgrad, med. J., Suppl. Nov., 67– 72. MAN IN t VELD, A.J., WENTING, G.J., VERHOEVEN, R.P. & SCHALEKAMP, M.A.D.H. (1978). Sympathetic and parasympathetic components of reflex cardiostimulation during vasodilator treatment of hypertension. Clin. Sci. mol. Med., 55, 329s– 332s. MAN IN t VELD, A.J., WENTING, G.J., BOOMSMA, F., VERHOEVEN, R.P. & SCHALEKAMP, M.A.D.H. (1980). Sympathetic and parasympathetic components of reflex cardiostimulation during vasodilator treatment of hypertension. Br. J. clin. Pharmac., 9, 547– 551. MASON, J.W., SPECTER, M.J., INGELS, N.B., DAUGTERS, G.T., FERRIS, A.C. & ALDERMAN, E.L. (1978). Haemodynamic effects of acebutolol. Br. Heart J., 40, 29– 34. MAZURKIEWICZ-KWILECKI, J.M. & ROMAGUOLI, A. (1970). Cardiac catecholamine levels and blood pressure after chronic treatment with β-adrenergic blocking agents. J. Pharm. Pharmac., 22, 235– 237. MONIZ-BETTENCOURT, J. & PINTO, B.G. (1970). Etude radiocardiographique des modifications de la dynamique cardiaque provoquees par le propranolol et le LB 46 Sandoz chez le sujet normal. Biol. Soc Port. Cardiol., 8, 353– 382. MORGAN, T.O., SABTO, J., ANAVEKAR, S.N., LOUIS, W.J. & DOYLE, A.E. (1974). A comparison of 0-adrenergic blocking drugs in the treatment of hypertension. Postgrad, med. J., 50, 253– 259. MORGAN, T.O., ROBERTS, R., CARNEY, S.L., LOUIS, W.J. & DOYLE, A.E. (1975). Beta-adrenergic receptor blocking drugs, hypertension and plasma renin. Br. J. clin. Pharmac., 2, 159– 164. MORGANTI, A., LOPEZ-OVEJERO, J.A., PICKERING, T.G., NIARCHOS, A.P. & LARAGH, J.H. (1978). Contrasting effects of acute β-blockade on plasma renin activity and plasma norepinephrine in essential hypertension. Clin. Pharmac. Ther., 23, 122. NEIL-DWYER, G., BARTLETT, J., McAINSH, J. & CRUICKSHANK, J. (1981). β-Adrenoceptor blockers and the blood-brain barrier. Br. J. clin. Pharmac., 11, 549– 553. PETRIE, J.G., GALLOWAY, D.B., WEBSTER, J., SIMPSON, W.T. & LEWIS, J.A. (1975). Atenolol and bcndro-fluazide in hypertension. Br. med. J., 3, 133– 135. PICKERING, T.G., GRIBBIN, B., PETERSON, E.S., CUNINGHAM, R.J. & SLEIGHT, P. (1972). Effects of autonomic blockade on the baroreflex in man at rest and during exercise. Circulation, 30, 177– 185. PINTO, B.G. (1972). Oradiocardiograma do doentes con angina de peito e suas modificacöes pela accäo do propranolol e do pindolol. Medico (Porto), 62, 51– 52. PRICHARD, B.N.C. (1964). Hypotensive action of pronethalol. Br. med. J., 1, 1227– 1228. PRICHARD, B.N.C. (1978). β-Adrenergic receptor blockade in hypertension, past, present and future. Br. J. clin. Pharmac., 5, 379– 399. RAHN, K.H., GIERLICHS, H.W.P.I., ANTZ, G., PLANTZ, R., SCHOLS, M. & STEPHANY, W. (1978). Studies on the effects of propranolol on plasma catecholamine levels in patients with essential hypertension. Eur. J. clin. Invest. 8, 143– 148. RAINE, A.E.G. & CHUBB, I.W. (1977). Long-term β-adrenergic blockade reduces tyrosine hydroxylase and dopamine β-hydroxylase activities in sympathetic ganglia. Nature, 267, 265– 267. RAINE, AEG, & PICKERING, T.G. (1977). Cardiovascular and sympathetic response to exercise after long-term beta-adrenergic blockade. Br. med. J., 2, 90– 92. REALE, A., NIGRI, A., AGOSTINO, P., MOTOLESE, M. (1979). Acute influence of different β-blocking agents upon left heart hemodynamics at rest and during exercise in patients with coronary artery disease. Eur. J. Cardiol., 9, 101– 109. SANNERSTEDT, R. (1976). Hemodynamic effects of adrenergic β-receptor blocking agents. Adv. clin. Pharmac., 11, 70– 78. SANNERSTEDT, R. & WASIR, H. (1977). Acute haemodynamic effects of metoprolol in hypertensive patients. Br. J. clin. Pharmac., 4, 23– 26. SAVENKOV, P.M., DOSHCHITSIN, V.L. & GRUBTSYN, G.V. (1977). The β-adrenergic blocker Visken (pindolol) for patients with arterial hypertension. Kardiologiya, 17, 62– 66. SIMON, G., KIOWSKI, W. & JULIUS, S. (1977). Effect of β-adrenoceptor antagonists on baroreceptor reflex sensitivity in hypertension. Clin. Pharmac. Ther., 22, 293– 298. SIMON, G., KIOWSKI, W. & JULIUS, S. (1979). Left ventricular performance during antihypertensive therapy with timolol. Curr. Ther. Res., 25, 626– 633. SIMPSON, F.O. (1974). Beta-adrenergic receptor blocking drugs in hypertension. Drugs, 7, 85– 105. STARKE, K. (1977). Regulation of noradrenaline release by presynaptic receptor systems. Rev. Physiol. Biochem. Pharmac., 77, 1– 24. STENBERG, J., WASIR, H., AMERY, A., SANNERSTEDT, R. & WERKÖ, L. (1975). Comparative hemodynamic studies in man of adrenergic β1-receptor agents without (H 93/26 = metoprolol) or with (H 87/07) intrinsicsym-pathomimetic activity. Acta Pharmac. Tox. 36, Suppl. V. 76– 84. STJÄRNE, L. & BRUNDIN, J. (1975). Dual adrenoceptor-mediated control of noradrenaline secretion from human vasoconstrictor nerves. Facilitation by fi-receptors and inhibition by β-receptors. Acta Physiol. Scand. 94, 139– 141. STJÄRNE, L. & BRUNDIN, J. (1976). Beta-adrenoceptors facilitating noradrenaline secretion from human vasoconstrictor nerves. Acta Physiol. Scand., 97, 88– 93. STOKES, G.S., WEBER, M.A. & THORNELL, I.R. (1974). Beta-blockers and plasma renin activity in hypertension. Br. med. J., 1, 60– 62. STRUYKER-BOUDIER, H.A.J., SMITS, J.F.M. & VAN ESSEN, H. (1979). The role of the baroreceptor reflex in the cardiovascular effects of propranolol in the conscious spontaneously hypertensive rat. Clin. Sci. mol. Med. 56, 163– 167. STUMPE, K.O., KOLLOCH, R., VETTER, H., GRAUMANN, W., KRÜCK, F., RESSEL, C.H. & HIGUCHI, H. (1976). Acute and long-term studies of the mechanism of action of beta-blocking drugs in lowering blood pressure. Am. J. Med., 60, 853– 865. SVENDSEN, T.L., CARLSEN, J.E., HARTLING, O., McNAIR, A. & TRAP-JENSEN, J. (1980). A comparison of the acute haemodynamic effects of propranolol and pindolol at rest and during supine exercise in man. Clin. Sci. mol. Med., 59, 465s– 468s. SVENSSON, A., GUDBRANSSON, T., SIVERTSON, R. & HANSSON, L. (1981). Metoprolol and pindolol in hypertension - different effects on peripheral haemodynamics. In Proceedings of the Eighth Scientific Meeting of the International Society of Hypertension, Milan, Italy, 31st May-3rd June. 1981, abstr. 439. TARAZI, R.C. & DUSTAN, H.P. (1972). Beta-adrenergic blockade in hypertension. Am. J. Cardiol., 29, 633– 640. TAYLOR, S.H., MAJID, P.A., SAXTON, C. & STOKER, J.B. (1970). Comparison of the circulatory effects of oxprenolol and propranolol in hypertensive patients. In Beta-adrenergic receptor blocking drugs. Proc. Symp. ed Simpson, F.O. Auckland, 1970. TSUKIYAMA, H., OTSUKA, K., MIYAMOTO, K., HASHIMOTO, M., YASUTAKE, S., HORII, M., MATSUI, Y., UEDA, A., TANAKA, T. & YAMAMOTO, Y. (1976). Hemodynamic effects of β-adrenergic blockade with pindolol, oxprenolol, propranolol and bufetolol hydrochloride in essential hypertension. Jap. circulation J., 40, 655– 664. UNDEUTSCH, K., SIEBERTH, H.G. & MEURER, K.A (1976). Beeinflussung der renalen Hypertonic durch der Beta-Receptorenblocker Pindolol. Klin. Wschr., 54, 1077– 1084. VANDENBURG, M.J., CONLON, C. & LEDINGHAM, J.M. (1981). A comparison of the effects of propranolol and oxprenolol on forearm blood flow and skin temperature. Br. J. clin. Pharmac., 11, 485– 490. VANDONGEN, R., DAVIDSON, L., BEILIN, L.J. & BARDEN, E.A. (1981). Effect of β-adrenergic receptor blockade with propranolol on the response of plasma catecholamines and renin activity to upright tilting in normal subjects. Br. J. clin. Pharmac., 12, 369– 374. VELASCO, M., QUINTANA, A.U., MORILLO, J., GUEVARA, J., RAMIREZ, A. & HERNANDEZ-PIERETTI, O. (1980). Cardiac and systemic hemodynamic effects of pindolol in hypertensive patients. Curr. Ther. Res., 28, 972– 979. WALE, J., PUN, L.Q. & RAND, M.J. (1969). The effects of ICI 50, 172, propranolol, pronethalol and MJ 1999 on beta-receptors. Eur. J. Pharmac., 8, 25– 35. WALTER, I., KUSUS, T., WAGNER, K. & LYDTIN, H. (1973). Die Wirkung eines β-Rezeptorenblocker auf das Herzminuut-volumen - Untersuchungen bei essentieller Hypertonic und hyperkinetischen Herzsyndrom unter Berücksichtigung der Plasma-Adrenaline und Noradrenaline-spiegel. Verh. Dtsch. Ges. Inn. Med., 79, 1010– 1013. WASSERMAN, A.J., PROCTOR, J.D., ALLEN, F.J. & KEMP, E. (1970). Human cardiovascular effects of alprenolol, a beta-adrenergic blocker: hemodynamic, antiarrythmic and antianginal. J. clin. Pharmac. 10, 37– 49. WEBER, M.A., STOKES, G.S. & GAIN, J.M. (1974). Comparison of the effects on renin release of β-adrenergic antagonists with differing properties. J. clin. Invest., 54, 1413– 1419. WEBSTER, J., JEFFERS, T.A., GALLOWAY, D.B., PETRIE, J.C. & BARKER, N.P. (1977). Atenolol, methyldopa and chloorthalidon in moderate hypertension. Br. med. J., 1, 76– 78. WILCOX, C.S., LEWIS, P.S., PEART, W.S., SEVER, P.S., OSIKOWSKA, B.A., SUDDLE, S.A.J., BLUHM, M.M., VEALL, N. & LANCASTER, R. (1981). Renal function, body fluid volumes, renin, aldosterone and noradrenaline during treatment of hypertension with pindolol. J. cardiov. Pharmac., 3, 598– 611. WILSON, D.F., WATSON, O.F., PEEL, J.S., LANGLEY, R.B. & TURNER, A.S. (1968). Some haemodynamic effects of Trasicor (Ciba 39, 089/Ba). N.Z. med. J., 68, 145– 149. WINER, N., CARTER, C.H., EDDY, H.E., GUSTAFSON, S.J. & BOLING, D.A. (1978). Pindolol vs methyldopa: a double-blind evaluation of effects on blood pressure, norepinephrine, and renin. Clin. Res., 26, 596a. WING, L.M., REID, J.L., HAMILTON, C., SEVER, P.E., DAVIES, D.S. & DOLLERY, C.T. (1977). Effects of clonidine on biochemical indices of sympathetic function and plasma renin activity in normotensive man. Clin. Sci. mol. Med., 53, 45– 53. WOLLAM, G.L., CODY, R.J., TARAZI, R.C. & BRAVO, E.L. (1979). Acute hemodynamic effects and cardioselectivity of acebutolol, practolol and propranolol. Clin. Pharmac. Ther., 25, 813– 820. YAMAGUCHI, N., DE CHAMPLAIN, J. & NADEAU, R.L. (1977). Regulation of norepinephrine release from cardiac sympathetic fibers in the dog by presynaptic alpha and beta receptors. Circulation Res., 41, 108– 117. ZAMORA, M.T. K. J.J. & CASTILLO, C. (1975). Efecto hemodinámico del bloqueo beta adrenérgico con pindolol en pacientes con hipertensión arterial esencial. Inv. Med. Int., 2, 132– 137. ZWEIFFLER, A.J. & ESLER, M. (1976). Dissociation of fall in blood pressure, renin activity and heart rate during propranolol therapy. Circulation, 54, Suppl. II, 87– 91. Citing Literature Volume13, IssueS2April 1982Pages 245S-257S ReferencesRelatedInformation

Referência(s)